Investing

BlackRock Technology & Private Equity Term Trust : BTX

BTX

Stock Data

$9.34

$0.34 (3.78%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Brooklyn ImmunoTherapeutics, Inc. (BTX) is a clinical-stage biopharmaceutical company focused on advancing innovative therapies for cancer treatment, leveraging its proprietary technology platforms. Headquartered in Brooklyn, New York, the company is committed to addressing unmet medical needs in oncology through the development of both cellular and genetic therapies. With a strong emphasis on research and development, Brooklyn ImmunoTherapeutics aims to improve patient outcomes and enhance the quality of life for cancer patients internationally.

All BlackRock Technology & Private Equity Term Trust Articles

1 Article

Lee Jackson | Oct 10, 2025 at 9:46 AM EDT

5 Stocks Under $10 With Huge Dividends and King-Size Upside Potential

Here are five stocks trading around the $5 to $10 level that offer investors ultra-high-yield dividends and king-size upside potential.